Ten years of I-Corps: The program that changed innovation
VentureWell looks back at launch of the National I-Corps program 10 years ago, and what the program has meant to inventors, researchers, and startups.
This tech startup is helping N. Philadelphians take control of their health
The founder, Deboleena (Deb) Dutta graduated from Wharton and participated in the PCI I-Corps program with Viora Health.
$10 Million gift establishes new Colton Center for Autoimmunity at Penn Medicine
Center brings together autoimmune disease researchers and clinicians to advance diagnosis and treatment
I-Corps graduate, Strella Biotechnology, featured in Washington Post story
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
Penn launches $750M investment in science, engineering, and medicine
President Amy Gutmann has announced the launch of a $750 million investment.
Applications are open for the 2022 PCI Fellows Program
PCI is seeking highly-talented, scientifically-trained Master’s and PhD students and post-doctoral researchers for the upcoming cohort of the Fellows Program.
Webinar Recording: Pennovation Works Resources
During this PCI webinar, Anish Kumar, the Managing Director of the Pennovation Works campus, discusses the past and future of Pennovation Works.
Webinar Recording: VC 101 for University Entrepreneurs
PCI hosted a webinar with Kirsten Leute and Margalit Haber of Osage University Partners on venture capital and investing for university entrepreneurs in the life science field
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
After setbacks, cell therapy for glioblastoma moves onto new chapter
At Penn, a leader in GBM cellular therapies since the early days of this technology, a new CAR cell therapy could find its way into clinical trials by next year in collaboration with Tmunity.